Biotech

All Articles

Rivus' period 2 obesity-related cardiac arrest trial attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its fat-busting, muscle-sparing medi...

Ovid stops preclinical job, IV plan after soticlestat fall short

.Ovid Therapeutics already disclosed final month that it was actually trimming back its own head cou...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has opened a $700 million R&ampD facility in the Boston ma Port, improving its RNA and DN...

Boundless Biography helps make 'reasonable' unemployments five months after $100M IPO

.Merely 5 months after safeguarding a $100 million IPO, Boundless Biography is actually actually lay...

Halda's $126M will definitely accelerate 'secure and eliminate' cyst medicines

.The first stages of oncology R&ampD aren't except interesting brand new modalities, and Halda Thera...

Lykos 'regrets' not disclosing research study transgressions along with author

.Psychopharmacology has drawn three short articles regarding midstage medical trial data assessing L...

Analysts dig into Avidity's DMD gain, showing nuances in data

.Avidity Biosciences impressed financiers along with stage 1/2 records in Duchenne muscle dystrophy ...

Actinogen's cortisol blocker fails phase 2 depression study

.Actinogen Medical's cortisol blocker has actually missed out on the main endpoint of a period 2 res...

Bivictrix chooses going personal only means to take ADC in to center

.Antibody-drug conjugates (ADCs) have actually been at the center of a lot of a billion-dollar biobu...

TPG leadings up funds to $580M for financial investments all over life scientific researches

.Asset manager TPG, which has sustained biotechs such as Sionna Therapeutics as well as Santa Clam A...